GS4 · UPSC Mains

Dr. Mehra is a senior drug developer at a leading pharmaceutical company in India, renowned for producing various medications, including lifesaving drugs critical for treating chronic and rare diseases. Since its inception, the company has emphasized the quality and affordability of its drugs. Recently, under revised government guidelines, pharmaceutical companies are required to market a finished product only after obtaining "satisfactory results" from tests on the ingredients. Additionally, they must retain a sufficient quantity of samples of both intermediate and final products to allow repeated testing or verification of a batch. Dr. Mehra's team is in the final stages of developing a new medication for a rare but life-threatening disease. This drug has shown promising results in clinical trials. However, there have been unresolved concerns about the long-term side effects of the drug, observed in a small percentage of trial subjects. Despite this, the company has not released any major drug in the past decade, leading to significant pressure from the board members to expedite the drug's release. (a) Identify the stakeholders in the above case study. (b) Discuss the ethical issues faced by Dr. Mehra. (c) Analyse the options available to Dr. Mehra in the above case. Which of these would you choose and why? (Answer in 250 words)

250 words · 42 toppers answered this

GS4 · Case studies on the above issues

Topper	Rank	Source	Copy
Saichaitanya Jadhav	—	VisionIAS	p.48
Dishant A Nisar	—	Vision	p.48
Mudita Agarwal	—	VisionIAS	p.48
Teshukant	—	VisionIAS	p.48
Ram Niwas Siyag	—	VisionIAS	p.48
Rajnish Patel	—	VisionIAS	p.48
Vipul Chaudhary	—	Vision	p.48
Vishwa Varddhan	—	VisionIAS	p.48
Sachin Basavaraj Guttur	—	VisionIAS	p.48
Trilok Singh	—	VisionIAS	p.48
Prachi Gupta	—	VisionIAS	p.48
Abhishek Anjani Singh	—	VisionIAS	p.48
Aayush Saini	—	VisionIAS	p.48
Rohit Singhal	—	VisionIAS	p.48
Surbhi Pathak	—	VisionIAS	p.48
Zinnia Aurora	—	Visionias	p.48
Nithin Pradeep	—	VisionIAS	p.48
Vijendra Kumar Meena	—	VisionIAS	p.48
Banna Venkatesh	—	VisionIAS	p.48
Prastuti Upadhaya	—	VisionIAS	p.48
Dipti Ranjan Pati	—	VisionIAS	p.48
Shilpa Chauhan	—	VisionIAS	p.48
Akansh Dhull	—	Vision	p.48
Ritika Pandey	—	VisionIAS	p.48
Jitendra Kumawat	—	VisionIAS	p.48
Simrandeep Kaur	—	Vision	p.48
R Rangamanju	—	VisionIAS	p.48
Tanvi Gupta	—	VisionIAS	p.48
Divyank Gupta	—	VisionIAS	p.48
Abhigyan Khaund	—	VisionIAS	p.48
Anurag Ranjan Vats	—	VisionIAS	p.48
Ashutosh Mishra	—	VisionIAS	p.48
Saloni Gautam	—	VisionIAS	p.48
Soumya Sharma	—	VisionIAS	p.48
Pawan Kumar Pandey	—	Vision	p.48
Vishwajeet Gupta	—	Visionias	p.48
Rajkesh Meena	—	VisionIAS	p.48
Eshani Anand	—	VisionIAS	p.48
Khetdan Charan	—	VisionIAS	p.48
Abhilash Sundaram	—	VisionIAS	p.48
Sanskriti Trivedy	—	VisionIAS	p.48
Utkarsh Pathak	—	VisionIAS	p.48